Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0296

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 80425-0296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement including a cyclohexane ring, a methoxy-substituted aromatic ring, and a dimethylaminoethyl side chain, labeled with venlafaxine hydrochloride text.*

FDA Label Image

Label 1 (Venlafaxine Er 75mg 80425 0296 01)

Venlafaxine hydrochloride ER 75 mg extended release capsule label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions, comparison to Effexor XR, lot number, expiration date, and a quantity of 30 capsules. Additional manufacturing information references Aurobindo Pharma.*

FDA Label Image

Label 2 (Venlafaxine Er 75mg 80425 0296 02)

Venlafaxine hydrochloride ER 75 mg extended release oral capsules from Advanced Rx Pharmacy of Tennessee, LLC. The green and white label includes product name, dosage strength, lot number, expiration date (10/31/2025), storage instructions (20-25°C), and a comparison to Effexor XR with relevant NDC numbers.*

FDA Label Image

Label 3 (Venlafaxine Er 75mg 80425 0296 03)

Venlafaxine hydrochloride ER 75 mg capsule extended release packaging label by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions at 20°-25°C (68°-77°F), comparison to Effexor XR, lot number, expiration date 10/31/2025, and manufacturer details including Aurobindo Pharma.*

FDA Label Image

Fig 1 (Fig 1)

A pharmacokinetic chart depicting fold changes and 90% confidence intervals for venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite across various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60, and gender differences. The chart plots changes relative to a reference value for Cmax and AUC parameters.*

FDA Label Image

Fig 2 (Fig 2)

A scatter plot chart displaying fold changes and 90% confidence intervals for the analyte venlafaxine with various interacting drugs. The x-axis represents fold change relative to a reference value from 0 to 3, and the y-axis lists interacting drugs such as Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The chart differentiates pharmacokinetic parameters Cmax and AUC for venlafaxine and oral desvenlafaxine (ODV).*

FDA Label Image

Fig 3 (Fig 3)

A forest plot showing the fold change and 90% confidence intervals for various pharmacokinetic parameters (Cmax and AUC) of multiple analytes related to interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents the change relative to a reference value, with data points indicating the effect size and confidence intervals for each analyte.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.